Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

for
Posterior Fossa Ependymal Tumor
Location: Durham NC, Washington D.C. DC, Baltimore MD,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 39

Code: NCT07226453

Phase 2, Recruiting

SickleFit Exercise and Nutrition Study

for
Sickle Cell Disease, Aging
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 35+

Code: NCT07442851

Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Durham NC, Chapel Hill NC, Kernersville NC,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Durham NC, New York NY, Mineola NY, Birmingham AL,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07246863

Phase 2, Recruiting

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Durham NC, Charleston SC, New York NY, Mineola NY,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07098988

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

for
Primary Progressive Multiple Sclerosis,
Location: Durham NC, Cincinnati OH, New York NY, St Louis MO,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT07477639

Phase 1, Phase 2, Recruiting

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for
Adenovirus Infections
Location: Durham NC, Washington D.C. DC, Philadelphia PA,
Sponsor: SymBio Pharmaceuticals

Sex: All

Age: 0+

Code: NCT07387367

Phase 3, Recruiting

129 Xenon Imaging in Patients Treated With Sotatercept

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18 - 70+

Code: NCT06351345

Phase 2, Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Durham NC, Myrtle Beach SC, Charlottesville VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Durham NC, Greenville NC, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase 2, Recruiting

Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial

for
Aortic Disorders
Location: Durham NC
Sponsor: Chandler Long, MD

Sex: All

Age: 18+

Code: NCT07064460

Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Durham NC, Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting

Enhancing Heart Allograft Function With the OCS Heart System Trial

for
Heart Transplant
Location: Durham NC, New York NY, Valhalla NY, Tampa FL,
Sponsor: TransMedics

Sex: All

Age: 18+

Code: NCT07145515

Recruiting

Prescription of Letrozole for Uterine Myoma

for
Leiomyoma, Uterine, Leiomyoma, Fibroid, Fibroid Uterus
Location: Durham NC, Jackson MS, Rochester MN, Los Angeles CA,
Sponsor: University of California, San Francisco

Sex: Female

Age: 21 - 53

Code: NCT06143631

Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Durham NC, Washington D.C. DC, Baltimore MD,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT07110246

Phase 2, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Durham NC, Charlotte NC, Charlottesville VA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Durham NC, Washington D.C. DC, Baltimore MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Durham NC, Myrtle Beach SC, Charleston SC,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07190300

Phase 1, Phase 2, Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Durham NC, Washington D.C. DC, Philadelphia PA,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase 3, Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Durham NC, Cincinnati OH, Cleveland OH, New York NY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting